Back to results
US 2018/0000902 A1Published application
Prevention of hypoglycaemia in diabetes mellitus type 2 patients
OwnerGabor Boka, Louise Silvestre +1inventors
InventorsGabor Boka, Louise Silvestre, Patrick Miossec
Life of this patent
Estimating the term…
Abstract
A method for the prevention of hypoglycaemia in diabetes mellitus type 2 comprising administering (a) desPro36Exendin-4(1-39)-Lys6-NH2 or/and a pharmaceutically acceptable salt thereof, and (b) a sulfonyl urea or/and a pharmaceutically acceptable salt thereof, to a subject in need thereof.
Claims12
A method for improving glycemic control in a type 2 diabetes mellitus patient comprising administering to the patient in need thereof:
- lixisenatide or a pharmaceutically acceptable salt thereof;
- wherein the patient is currently receiving treatment with a sulfonylurea.
A method for improving glycemic control in a type 2 diabetes mellitus patient currently receiving treatment with a sulfonylurea, the method comprising:
- administering to the patient lixisenatide or a pharmaceutically acceptable salt thereof;
- and
- reducing the dose of the sulfonylurea treatment if the patient has an increased risk of hypoglycemia.
Dependencies are inferred from the claim text.